Ijichi Nobuhiro

イヂチノブヒロ | Ijichi Nobuhiro

Affiliation and department：
Homepage URL (1)： http://www.kufm.kagoshima-u.ac.jp/~anatomy2/index.html

Research field (1)： Molecular biology

Research theme for competitive and other funds (13)：

2022 - 2025 多面的な抗腫瘍免疫誘導をもたらす革新的ながん免疫ウイルス併用療法の開発
2020 - 2023 増殖型ウイルス/CAR-T融合による革新的な癌免疫遺伝子・細胞治療技術の創出
2020 - 2023 骨軟部腫瘍を制圧できる全身性癌免疫誘導の革新的な免疫遺伝子・ウイルス治療の開発
2019 - 2022 Development of innovative immunovirotherapy facilitating anti-tumor immunity in bone and soft tissue tumors
2017 - 2020 Development of Innovative Gene-Virus Therapy for Tumor Lysis, Immunity Induction, and Cancer Stem Cell Suppression in Bone and Soft Tissue Sarcoma.

Show all

Papers (14)：

小戝健一郎, 永野聡, 伊地知暢広, 二川俊隆, 角栄里子, 山口宗一, 中條正典, 橋口照人, 武田泰生, 吉浦敬, et al. トランスレーショナルリサーチの現状と展望次世代の腫瘍溶解性ウイルス・免疫遺伝子治療の独自開発と実用化を目指したFirst-in-human医師主導治験(Current status and prospects in translational research Development of next-generation oncolytic viro-immuno-therapy and investigator-initiated first-in-human clinical trial). 日本癌学会総会記事. 2018. 77回. 1826-1826
Kanako Ide, Kaoru Mitsui, Rie Irie, Yohei Matsushita, Nobuhiro Ijichi, Soichiro Toyodome, Ken-Ichiro Kosai. A Novel Construction of Lentiviral Vectors for Eliminating Tumorigenic Cells from Pluripotent Stem Cells. Stem Cells. 2018. 36. 2. 230-239
Nobuhiro Ijichi, Takashi Shigekawa, Kazuhiro Ikeda, Toshiaki Miyazaki, Kuniko Horie-Inoue, Chikako Shimizu, Shigehira Saji, Kenjiro Aogi, Hitoshi Tsuda, Akihiko Osaki, et al. Association of positive EBAG9 immunoreactivity with unfavorable prognosis in breast cancer patients treated with tamoxifen. Clinical Breast Cancer. 2013. 13. 6. 465-470
Nobuhiro Ijichi, Kazuhiro Ikeda, Kuniko Horie-Inoue, Satoshi Inoue. FOXP1 and Estrogen Signaling in Breast Cancer. Vitamins and Hormones. 2013. 93. 203-212
Nobuhiro Ijichi, Takashi Shigekawa, Kazuhiro Ikeda, Kuniko Horie-Inoue, Chikako Shimizu, Shigehira Saji, Kenjiro Aogi, Hitoshi Tsuda, Akihiko Osaki, Toshiaki Saeki, et al. Association of Double-Positive FOXA1 and FOXP1 Immunoreactivities with Favorable Prognosis of Tamoxifen-Treated Breast Cancer Patients. HORMONES & CANCER. 2012. 3. 4. 147-159

ｍore...

MISC (8)：

T. Shigekawa, N. Ijichi, K. Ikeda, T. Miyazaki, K. Horie-Inoue, C. Shimizu, S. Saji, K. Aogi, H. Tsuda, A. Osaki, et al. EBAG9 immunoreactivity is a potential prognostic factor for poor outcome of breast cancer patients with adjuvant tamoxifen therapy. CANCER RESEARCH. 2012. 72
T. Shigekawa, N. Ijichi, K. Ikeda, K. Horie-Inoue, C. Shimizu, S. Saji, K. Aogi, H. Tsuda, A. Osaki, T. Saeki, et al. An Estrogen-Inducible Transcription Factor FOXP1 Promotes Estrogen-Dependent Cell Proliferation of Breast Cancer Cells and Is Associated with 5-Year Disease-Free Survival in Patients with Tamoxifen-Treated Breast Cancer. CANCER RESEARCH. 2011. 71
T. Shigekawa, N. Ijichi, S. Takayama, H. Tsuda, K. Ikeda, K. Horie, A. Osaki, T. Saeki, S. Inoue. AXILLARY ULTRASOUND EXAMINATION IS USEFUL FOR SELECTING OPTIMAL PATIENTS SUITED FOR SENTINEL NODE BIOPSY AFTER PRIMARY SYSTEMIC CHEMOTHERAPY (JAPAN). JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2011. 41. 3. I14-I14
重川崇, 伊地知暢広, 池田和博, 津田均, 佐伯俊昭, 井上聡. 【乳癌のバイオロジーと臨床診断と治療への応用】乳癌におけるフォークヘッド転写因子群の役割. 乳癌の臨床. 2010. 25. 5. 515-521
Mayumi Kubo, Nobuhiro Ijichi, Kazuhiro Ikeda, Kuniko Horie-Inoue, Satoru Takeda, Satoshi Inoue. Estrogen-related receptor gamma modulates adipogenesis-related gene expression during adipocytic differentiation. ENDOCRINE JOURNAL. 2010. 57. S548-S548

ｍore...

Books (2)：

次世代がん治療
2017
Adipocytes: Biology, Regulation and Health Impact
Nova Science Publishers 2012

Education (3)：

2001 - 2004 九州大学大学院医学系学府分子生命科学系専攻(博士)
1999 - 2001 九州大学大学院理学研究科生物科学専攻(修士)
1995 - 1999 Kyushu University School of Sciences Department of Biology

Professional career (1)：

理学博士 (九州大学大学院)

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page